The role of acid inhibition in Helicobacter pylori eradication [version 1; referees: 3 approved]

Abstract

Infection of the stomach by the gastric pathogen Helicobacter pylori results in chronic active gastritis and leads to the development of gastric and duodenal ulcer disease and gastric adenocarcinoma. Eradication of H. pylori infection improves or resolves the associated pathology. Current treatments of H. pylori infection rely on acid suppression in combination with at least two antibiotics. The role of acid suppression in eradication therapy has been variously attributed to antibacterial activity of proton pump inhibitors directly or through inhibition of urease activity or increased stability and activity of antibiotics. Here we discuss the effect of acid suppression on enhanced replicative capacity of H. pylori to permit the bactericidal activity of growth-dependent antibiotics. The future of eradication therapy will rely on improvement of acid inhibition along with current antibiotics or the development of novel compounds targeting the organism’s ability to survive in acid.

Keywords

• Antimicrobials & Drug Resistance
• Bacterial Infections
• Epidemiology
• Gastrointestinal Infections
• Gastrointestinal Pharmacology
• Gastrointestinal Physiology
• Medical Microbiology
• Stomach & Duodenum